Enhancing Scars with Platelet Rich Plasma: A Healthier Look

Efficacy of Platelet rich plasma in reducing the scar width of primary cleft lip repair; a double-blinded randomized control trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/061196

Enrollment

Registered

2024-01-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q369- Cleft lip, unilateral

Interventions

Intervention1: Platelet rich plasma: 2- 6 month old age group intra opertative administration of platelet rich plasma over suture line Dose 0.25 ml 1st during muscle layer closure then during skin l

Eligibility

Inclusion criteria

Inclusion criteria: i) Non-syndromic complete unilateral cleft lip ii) American Society of Anesthesiologists (ASA) grade 1 and 2 iii) Consenting to participate iv) Not a part of any other trial or research project

Exclusion criteria

Exclusion criteria: i) Syndromic patients ii) Very wide cleft lip iii) Children with neuromuscular disorders iv) Not willing for consent

Design outcomes

Primary

Measure	Time frame
Scar width of lip repair clinically and with ultrasound in mm in intervention group and controlTimepoint: 6 months	—

Secondary

Measure	Time frame
1) To evaluate the scar quality based on the Vancouver scar scale 2) To determine Incidence of Surgical site infection (SSI) Timepoint: 6 months	—

Countries

India

Contacts

Public ContactDr Ansarul Haq

All India Institute of Medical Sciences Pata

drsveena@aiimspatna.org9905755111

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026